Safe Medicine Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 5575.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. POSEY, as printed in the Congressional Record (Vol. 169, No. 151, September 19, 2023, Page H4409):
  Article I, Section 8 The single subject of this legislation is: A bill to direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination.
  Source: Congress.gov, Congressional Record September 19, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  410 characters

  Congress.gov bill record

  H.R. 5575, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/5575

  Record last updated by Congress.gov

  June 6, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  86cf99984aeb79a8303eb67b26dd1d6485e84721ac288b12fd1b4333395b7716

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of June 6, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 5575, last updated June 6, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.